174 related articles for article (PubMed ID: 11084687)
1. Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa.
Dellambra E; Pellegrini G; Guerra L; Ferrari G; Zambruno G; Mavilio F; De Luca M
Hum Gene Ther; 2000 Nov; 11(16):2283-7. PubMed ID: 11084687
[TBL] [Abstract][Full Text] [Related]
2. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.
Mavilio F; Pellegrini G; Ferrari S; Di Nunzio F; Di Iorio E; Recchia A; Maruggi G; Ferrari G; Provasi E; Bonini C; Capurro S; Conti A; Magnoni C; Giannetti A; De Luca M
Nat Med; 2006 Dec; 12(12):1397-402. PubMed ID: 17115047
[TBL] [Abstract][Full Text] [Related]
3. Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa.
Dellambra E; Vailly J; Pellegrini G; Bondanza S; Golisano O; Macchia C; Zambruno G; Meneguzzi G; De Luca M
Hum Gene Ther; 1998 Jun; 9(9):1359-70. PubMed ID: 9650620
[TBL] [Abstract][Full Text] [Related]
4. Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa - 5-Year Outcomes.
Kueckelhaus M; Rothoeft T; De Rosa L; Yeni B; Ohmann T; Maier C; Eitner L; Metze D; Losi L; Secone Seconetti A; De Luca M; Hirsch T
N Engl J Med; 2021 Dec; 385(24):2264-2270. PubMed ID: 34881838
[TBL] [Abstract][Full Text] [Related]
5. Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa.
De Rosa L; Carulli S; Cocchiarella F; Quaglino D; Enzo E; Franchini E; Giannetti A; De Santis G; Recchia A; Pellegrini G; De Luca M
Stem Cell Reports; 2014 Jan; 2(1):1-8. PubMed ID: 24511464
[TBL] [Abstract][Full Text] [Related]
6. In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa.
Robbins PB; Lin Q; Goodnough JB; Tian H; Chen X; Khavari PA
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5193-8. PubMed ID: 11296269
[TBL] [Abstract][Full Text] [Related]
7. BP180 gene delivery in junctional epidermolysis bullosa.
Seitz CS; Giudice GJ; Balding SD; Marinkovich MP; Khavari PA
Gene Ther; 1999 Jan; 6(1):42-7. PubMed ID: 10341874
[TBL] [Abstract][Full Text] [Related]
8. Regeneration of the entire human epidermis using transgenic stem cells.
Hirsch T; Rothoeft T; Teig N; Bauer JW; Pellegrini G; De Rosa L; Scaglione D; Reichelt J; Klausegger A; Kneisz D; Romano O; Secone Seconetti A; Contin R; Enzo E; Jurman I; Carulli S; Jacobsen F; Luecke T; Lehnhardt M; Fischer M; Kueckelhaus M; Quaglino D; Morgante M; Bicciato S; Bondanza S; De Luca M
Nature; 2017 Nov; 551(7680):327-332. PubMed ID: 29144448
[TBL] [Abstract][Full Text] [Related]
9. Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa.
De Rosa L; Secone Seconetti A; De Santis G; Pellacani G; Hirsch T; Rothoeft T; Teig N; Pellegrini G; Bauer JW; De Luca M
Cell Rep; 2019 May; 27(7):2036-2049.e6. PubMed ID: 31091444
[TBL] [Abstract][Full Text] [Related]
10. PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa.
Ortiz-Urda S; Thyagarajan B; Keene DR; Lin Q; Calos MP; Khavari PA
Hum Gene Ther; 2003 Jun; 14(9):923-8. PubMed ID: 12828862
[TBL] [Abstract][Full Text] [Related]
11. Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia.
Vailly J; Gagnoux-Palacios L; Dell'Ambra E; Roméro C; Pinola M; Zambruno G; De Luca M; Ortonne JP; Meneguzzi G
Gene Ther; 1998 Oct; 5(10):1322-32. PubMed ID: 9930337
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient.
Benati D; Miselli F; Cocchiarella F; Patrizi C; Carretero M; Baldassarri S; Ammendola V; Has C; Colloca S; Del Rio M; Larcher F; Recchia A
Mol Ther; 2018 Nov; 26(11):2592-2603. PubMed ID: 30122422
[TBL] [Abstract][Full Text] [Related]
13. Leading edge: emerging drug, cell, and gene therapies for junctional epidermolysis bullosa.
Keith AR; Twaroski K; Ebens CL; Tolar J
Expert Opin Biol Ther; 2020 Aug; 20(8):911-923. PubMed ID: 32178539
[TBL] [Abstract][Full Text] [Related]
14. Towards a gene therapy clinical trial for epidermolysis bullosa.
Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
Rev Recent Clin Trials; 2006 May; 1(2):155-62. PubMed ID: 18473966
[TBL] [Abstract][Full Text] [Related]
15. Correction of laminin-5 deficiency in human epidermal stem cells by transcriptionally targeted lentiviral vectors.
Di Nunzio F; Maruggi G; Ferrari S; Di Iorio E; Poletti V; Garcia M; Del Rio M; De Luca M; Larcher F; Pellegrini G; Mavilio F
Mol Ther; 2008 Dec; 16(12):1977-85. PubMed ID: 18813277
[TBL] [Abstract][Full Text] [Related]
16. Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer.
Ortiz-Urda S; Lin Q; Yant SR; Keene D; Kay MA; Khavari PA
Gene Ther; 2003 Jul; 10(13):1099-104. PubMed ID: 12808440
[TBL] [Abstract][Full Text] [Related]
17. Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant.
Melo SP; Lisowski L; Bashkirova E; Zhen HH; Chu K; Keene DR; Marinkovich MP; Kay MA; Oro AE
Mol Ther; 2014 Apr; 22(4):725-33. PubMed ID: 24390279
[TBL] [Abstract][Full Text] [Related]
18. Gentamicin induces
Lincoln V; Cogan J; Hou Y; Hirsch M; Hao M; Alexeev V; De Luca M; De Rosa L; Bauer JW; Woodley DT; Chen M
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6536-E6545. PubMed ID: 29946029
[TBL] [Abstract][Full Text] [Related]
19. Impact of laminin 5 beta3 gene versus protein replacement on gene expression patterns in junctional epidermolysis bullosa.
Robbins PB; Sheu SM; Goodnough JB; Khavari PA
Hum Gene Ther; 2001 Jul; 12(11):1443-8. PubMed ID: 11485635
[TBL] [Abstract][Full Text] [Related]
20. Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy.
Gostynski A; Deviaene FC; Pasmooij AM; Pas HH; Jonkman MF
Br J Dermatol; 2009 Aug; 161(2):444-7. PubMed ID: 19416258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
